Comparative Tolerability of Intravenous Azithromycin, Clarithromycin and Erythromycin in Healthy Volunteers: Results of a Double-Blind, Double-Dummy, Four-Way Crossover Study

By Zimmermann T.  

Clinical Drug Investigation, Vol. 21, Iss. 8, 2001-08 ,pp. : 527-536

Adis International

Access to resources Recommend Favorite

Efficacy, Onset of Action and Tolerability of Moxifloxacin in Patients with Community-Acquired Pneumonia: Results of a Postmarketing Surveillance Study

By Landen H.  

Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Generic versus Non-Generic Formulation of Extended-Release Clarithromycin in Patients with Community-Acquired Respiratory Tract Infections: A Prospective, Randomized, Comparative, Investigator-Blind, Multicentre Study

By Snyman J.R.  

Clinical Drug Investigation, Vol. 29, Iss. 4, 2009-01 ,pp. : 265-274

Adis International

Access to resources Recommend Favorite

The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia

By Bewick Thomas   Greenwood Sonia   Lim Wei Shen  

Clinical Medicine, Vol. 10, Iss. 6, 2010-12 ,pp. : 563-567

Royal College Of Physicians

Access to resources Recommend Favorite

Intravenous/Oral Sequential Therapy in Patients Hospitalised with Community-Acquired Pneumonia: Which Patients, When and What Agents?

By Vogel F.  

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 309-317

Adis International

Access to resources Recommend Favorite